|
시장보고서
상품코드
1890960
리소자임(Lysozyme) 시장 : 치료 용도별, 제품 유형별, 제형별, 투여 경로별, 제제 유형별, 최종사용자별, 유통 채널별, 지역별Lysozyme Market, By Therapeutic Application, By Product Type, By Form, By Route of Administration, By Formulation Type, By End User, By Distribution Channel, By Geography |
||||||
리소자임 시장은 2025년에 6억 590만 달러로 추정되며, 2032년까지 9억 9,220만 달러에 달할 것으로 전망됩니다. 2025-2032년까지 CAGR 7.3%로 성장할 전망입니다.
| 보고서 커버 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2024년 | 2025년 시장 규모: | 6억 590만 달러 |
| 과거 데이터 대상 기간: | 2020-2024년 | 예측 기간: | 2025-2032년 |
| 예측 기간 2025-2032년: | 7.30% | 2032년 예측치: | 9억 9,220만 달러 |
세계 리소자임 시장은 생명공학 및 제약 산업에서 중요한 부문을 차지하고 있으며, 천연 유래 항균 효소의 다기능적 특성에 의해 주도되고 있습니다. 주로 달걀 흰자, 인체 분비물, 박테리아에서 유래한 리소자임은 식품 보존에서 의약품 제제에 이르기까지 다양한 용도에서 중요한 성분으로 작용합니다. 이 효소가 박테리아의 세포벽을 분해하는 능력은 미생물 감염과 싸우고 여러 산업에서 제품의 유통기한을 연장하는 데 있어 매우 귀중한 자산이 되고 있습니다.
시장에는 난백 유래 리소자임, 인간 유래 리소자임, 재조합 리소자임 등 다양한 제품 유형이 존재하며, 각각 특정 산업 수요에 대응하고 있습니다. 주요 응용 분야는 식음료, 의약품, 퍼스널케어 제품, 동물 사료 등이며, 리소팀의 천연 항균 특성은 합성 방부제를 대체할 수 있는 지속가능한 대안이 될 수 있습니다. 천연 성분을 선호하는 소비자의 증가 추세와 식품 안전 및 의약품 품질에 대한 엄격한 규제 프레임워크가 결합되어, 리소팀은 효과적이고 천연적인 항균 솔루션을 찾는 제조업체들에게 우선적인 선택이 되고 있습니다. 시장의 성장 궤적은 생명공학 연구의 발전, 혁신적인 생산 방식, 신흥 치료 분야에서의 적용 확대에 힘입어 더욱 가속화되고 있으며, 이 분야는 상업적 잠재력이 큰 역동적이고 진화하는 분야로 부상하고 있습니다.
시장 역학
세계 리소자임 시장은 몇 가지 주요 촉진요인에 의해 견인되어 견고한 성장 궤도를 유지하고 있습니다. 주요 촉진요인은 소비자들이 클린 라벨 제품을 점점 더 중요시하고 제조업체들이 합성 방부제를 대체할 수 있는 대안을 찾으면서 식품, 제약 및 퍼스널케어 산업 전반에 걸쳐 천연 항균제에 대한 수요가 증가하고 있다는 점입니다. 특히 개발도상국에서의 식음료 부문의 확대는 식품 보존 부문에서 리소자임 적용에 큰 기회를 창출하고 있습니다. 한편, 제약 산업이 천연 치료 화합물을 중시하는 경향이 강화되는 가운데, 제약 등급 리소자임은 제약 제제 및 상처 치료 용도의 수요를 주도하고 있습니다. 또한, 항생제 내성에 대한 인식이 높아지는 가운데, 다양한 병원성 미생물에 대한 효능을 입증한 광범위한 연구 결과에 힘입어 리소자임은 매력적인 대체 항균제로 자리매김하고 있습니다.
그러나 시장에는 심각한 제약도 존재합니다. 리소자임 추출 및 정제 공정에 따른 높은 생산 비용으로 인해, 비용 중심의 응용 분야와 신흥 시장에서의 채택이 제한되고 있습니다. 특히 계란 흰자 원료의 수급 제약은 공급망상의 문제이며, 지역별 규제의 복잡성은 시장 진입과 제품 표준화의 장벽으로 작용하고 있습니다. 특정 조건에서의 낮은 저장 안정성과 과민한 개인의 잠재적 알레르기 반응은 시장 확대를 더욱 제한하는 요인으로 작용할 수 있습니다. 그러나 바이오기술의 발전으로 재조합 리소자임 생산이 가능해짐에 따라 공급 제한과 알레르기 우려를 해소하고, 생산비용 절감의 가능성을 지닌 재조합 리소자임 생산이 가능해짐에 따라 큰 기회가 생기고 있습니다. 성장하는 뉴트리슈티컬 시장, 수의학 분야에서의 적용 확대, 개발도상국에서의 채택 증가, 다양한 질병 치료에 대한 잠재적 치료 응용은 리소팀의 다양한 기능적 특성을 활용하고자 하는 시장 진입 기업들에게 수익성 높은 성장의 길을 제시하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)을 제시하는 세계 리조팀 시장에 대한 상세한 분석을 제공합니다.
- 각 부문의 잠재적 수익 기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하였습니다.
- 시장 촉진요인, 저해요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 정보를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 리조팀 시장의 주요 참가자의 프로필을 제시합니다. 회사 개요,제품 포트폴리오,주요 하이라이트,재무 실적,전략
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 리조팀 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 리조팀 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
- 조사 목적
- 가정
- 약어
제2장 시장 범위
- 보고서 개요
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 규제 환경
- 제품 발매·승인
- PEST 분석
- Porters 분석
- 인수합병 동향
- 산업 동향
제4장 세계의 리소자임 시장 : 치료 용도별, 2020-2032년
- 항감염 요법
- 항염증 요법
- 소화기 감염증 관리
- 호흡기 감염 관리
- 상처 치료와 조직 수복
- 면역조절 요법
- 기타
제5장 세계의 리소자임 시장 : 제품 유형별, 2020-2032년
- 재조합 리소자임
- 천연 리소자임
제6장 세계의 리소자임 시장 : 제형별, 2020-2032년
- 리소자임 용액
- 리소자임 분말
제7장 세계의 리소자임 시장 : 투여 경로별, 2020-2032년
- 경구
- 비경구
- 외용
- 기타(비강내)
제8장 세계의 리소자임 시장 : 제제 유형별, 2020-2032년
- 단독요법
- 병용요법
제9장 세계의 리소자임 시장 : 최종사용자별, 2020-2032년
- 제약 제조업체
- 바이오테크놀러지 기업
- 병원과 클리닉
- 연구기관
제10장 세계의 리소자임 시장 : 유통 채널별, 2020-2032년
- 온라인
- 오프라인
제11장 세계의 리소자임 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제12장 경쟁 구도
- dsm-firmenich
- Bioseutica BV
- WAKO Chemicals
- Danish Bioscience
- Qingdao Vland BIoTech
- Amano Enzyme Inc
- Lysozyme Corporation
- Nanning Doing-Higher Bio-Tech
- Jiangsu Yiming Biological
- Jiangxi Shineway Pharmaceutical
- Handary SA
- Bouwhuis Enthoven
- AgraFood Ingredients BV
- Neova Technologies
- Chr Hansen A/S
제13장 애널리스트의 추천사항
- 기회
- Coherent Opportunity Map
제14장 참고문헌과 조사 방법
- 참고문헌
- 조사 방법
- 출판사 소개
Lysozyme Market is estimated to be valued at USD 605.9 Mn in 2025 and is expected to reach USD 992.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 605.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.30% | 2032 Value Projection: | USD 992.2 Mn |
The global lysozyme market represents a significant segment within the biotechnology and pharmaceutical industries, driven by the multifunctional properties of this naturally occurring antimicrobial enzyme. Lysozyme, primarily derived from egg whites, human secretions, and bacterial sources, serves as a crucial component in various applications ranging from food preservation to pharmaceutical formulations. This enzyme's ability to break down bacterial cell walls makes it an invaluable asset in combating microbial infections and extending product shelf life across multiple industries.
The market encompasses diverse product types including egg white lysozyme, human lysozyme, and recombinant lysozyme, each serving specific industrial requirements. Key application sectors include food and beverages, pharmaceuticals, personal care products, and animal feed, where lysozyme's natural antimicrobial properties provide sustainable alternatives to synthetic preservatives. The increasing consumer preference for natural ingredients, coupled with stringent regulatory frameworks governing food safety and pharmaceutical quality, has positioned lysozyme as a preferred choice for manufacturers seeking effective yet natural antimicrobial solutions. The market's growth trajectory is further supported by advancing biotechnology research, innovative production methods, and expanding applications in emerging therapeutic areas, making it a dynamic and evolving sector with substantial commercial potential.
Market Dynamics
The global lysozyme market is propelled by several key drivers that collectively contribute to its robust growth trajectory, with the primary driver being the escalating demand for natural antimicrobial agents across food, pharmaceutical, and personal care industries as consumers increasingly prioritize clean-label products and manufacturers seek alternatives to synthetic preservatives. The expanding food and beverage sector, particularly in developing economies, creates substantial opportunities for lysozyme application in food preservation, while the growing pharmaceutical industry's focus on natural therapeutic compounds drives demand for pharmaceutical-grade lysozyme in drug formulations and wound healing applications. Additionally, the rising awareness of antibiotic resistance has positioned lysozyme as an attractive alternative antimicrobial agent, supported by extensive research demonstrating its efficacy against various pathogenic microorganisms.
However, the market faces significant restraints including the high production costs associated with lysozyme extraction and purification processes, which limit its adoption in cost-sensitive applications and emerging markets. Raw material availability constraints, particularly concerning egg white sources, pose supply chain challenges, while regulatory complexities across different regions create barriers to market entry and product standardization. The limited shelf stability of lysozyme under certain conditions and potential allergenic reactions in sensitive individuals further constrain market expansion. Nevertheless, substantial opportunities emerge from advancing biotechnology enabling recombinant lysozyme production, which addresses supply limitations and allergenicity concerns while potentially reducing production costs. The expanding nutraceutical market, growing applications in veterinary medicine, increasing adoption in developing regions, and potential therapeutic applications in treating various diseases present lucrative growth avenues for market participants seeking to capitalize on lysozyme's diverse functional properties.
Key Features of the Study
- This report provides in-depth analysis of the global lysozyme market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global lysozyme market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include dsm-firmenich, Bioseutica BV, WAKO Chemicals, Danish Bioscience, Qingdao Vland Biotech, Amano Enzyme Inc, Lysozyme Corporation, Nanning Doing-Higher Bio-Tech, Jiangsu Yiming Biological, Jiangxi Shineway Pharmaceutical, Handary SA, Bouwhuis Enthoven, AgraFood Ingredients BV, Neova Technologies, and Chr Hansen A/S
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global lysozyme market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lysozyme market
Market Segmentation
- Therapeutic Application Insights (Revenue, USD Mn, 2020 - 2032)
- Anti-infective Therapies
- Anti-inflammatory Therapies
- Gastrointestinal Infection Management
- Respiratory Infection Management
- Wound-Healing and Tissue Repair
- Immunomodulatory Applications
- Other Therapeutic Uses
- Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Recombinant Lysozyme
- Natural Lysozyme
- Form Insights (Revenue, USD Mn, 2020 - 2032)
- Lysozyme Solution
- Lysozyme Powder
- Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
- Oral
- Parenteral
- Topical
- Others (Nasal)
- Formulation Type Insights (Revenue, USD Mn, 2020 - 2032)
- Monotherapies
- Combination Therapies
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Pharmaceutical Manufacturers
- Biotechnology Companies
- Hospitals and Clinics
- Research Institutes
- Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Online
- Offline
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- dsm-firmenich
- Bioseutica BV
- WAKO Chemicals
- Danish Bioscience
- Qingdao Vland Biotech
- Amano Enzyme Inc
- Lysozyme Corporation
- Nanning Doing-Higher Bio-Tech
- Jiangsu Yiming Biological
- Jiangxi Shineway Pharmaceutical
- Handary SA
- Bouwhuis Enthoven
- AgraFood Ingredients BV
- Neova Technologies
- Chr Hansen A/S
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Lysozyme Market, By Therapeutic Application
- Global Lysozyme Market, By Product Type
- Global Lysozyme Market, By Form
- Global Lysozyme Market, By Route of Administration
- Global Lysozyme Market, By Formulation Type
- Global Lysozyme Market, By End User
- Global Lysozyme Market, By Distribution Channel
- Global Lysozyme Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Lysozyme Market, By Therapeutic Application, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Anti-infective Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Anti-inflammatory Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Gastrointestinal Infection Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Respiratory Infection Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Wound-Healing and Tissue Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Immunomodulatory Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Other Therapeutic Uses
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Lysozyme Market, By Product Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Recombinant Lysozyme
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Natural Lysozyme
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Lysozyme Market, By Form, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Lysozyme Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Lysozyme Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Lysozyme Market, By Route of Administration, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (Nasal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Lysozyme Market, By Formulation Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Monotherapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Combination Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Lysozyme Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
10. Global Lysozyme Market, By Distribution Channel, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
11. Global Lysozyme Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- dsm-firmenich
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bioseutica BV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WAKO Chemicals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danish Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qingdao Vland Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amano Enzyme Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lysozyme Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanning Doing-Higher Bio-Tech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jiangsu Yiming Biological
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jiangxi Shineway Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Handary SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bouwhuis Enthoven
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AgraFood Ingredients BV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neova Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Chr Hansen A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
